Cabaletta Bio, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 02/14/2025 | 4.07 M | $9.25 M | 10.90% | 8.32% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 02/14/2025 | 3.63 M | $8.25 M | 19.69% | 7.43% |
| BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 3.40 M | $7.71 M | -29.13% | 6.94% |
| VANGUARD GROUP INC | 02/11/2025 | 2.87 M | $6.51 M | 12.30% | 5.86% |
| BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC | 02/14/2025 | 2.76 M | $6.27 M | 0.00% | 5.64% |
| JENNISON ASSOCIATES LLC | 01/24/2025 | 2.51 M | $5.70 M | -55.40% | 5.13% |
| FRED ALGER MANAGEMENT, LLC | 02/14/2025 | 2.32 M | $5.26 M | -43.77% | 4.73% |
| POINT72 ASSET MANAGEMENT, L.P. | 02/14/2025 | 1.27 M | $2.87 M | 89.71% | 2.59% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 1.11 M | $2.52 M | 1.47% | 2.27% |
| STATE STREET CORP | 02/14/2025 | 937,978 | $2.13 M | 4.67% | 1.92% |
| TWO SIGMA ADVISERS, LP | 02/14/2025 | 831,900 | $1.89 M | 195.84% | 1.70% |
| SUPERSTRING CAPITAL MANAGEMENT LP | 02/14/2025 | 822,293 | $1.87 M | 523.92% | 1.68% |
| TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 751,894 | $1.71 M | 78.82% | 1.54% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/14/2025 | 524,087 | $1.19 M | -5.19% | 1.07% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 511,613 | $1.16 M | -68.59% | 1.05% |
| GOLDMAN SACHS GROUP INC | 02/11/2025 | 511,515 | $1.16 M | 59.17% | 1.05% |
| ACADIAN ASSET MANAGEMENT LLC | 02/11/2025 | 500,264 | $1.13 M | 94.34% | 1.02% |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 02/14/2025 | 500,000 | $1.14 M | 11.11% | 1.02% |
| UBS GROUP AG | 02/14/2025 | 434,557 | $986,444 | 1,808.13% | 0.89% |
| NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 434,389 | $986,063 | 0.00% | 0.89% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 431,935 | $980,492 | 1,749.67% | 0.88% |
| PRUDENTIAL FINANCIAL INC | 02/11/2025 | 286,810 | $651,059 | 0.00% | 0.59% |
| AXA S.A. | 02/14/2025 | 270,423 | $613,860 | -0.16% | 0.55% |
| JPMORGAN CHASE & CO | 02/12/2025 | 259,392 | $588,819 | -7.34% | 0.53% |
| HEALTHINVEST PARTNERS AB | 02/04/2025 | 247,454 | $554,297 | 46.84% | 0.51% |
| RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 230,161 | $522,465 | 100.00% | 0.47% |
| 02/14/2025 | 220,000 | $492,800 | 100.00% | 0.45% | |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 02/14/2025 | 217,802 | $494,410 | -62.00% | 0.45% |
| MARSHALL WACE, LLP | 02/13/2025 | 193,225 | $438,622 | -31.92% | 0.39% |
| 02/12/2025 | 190,000 | $431,300 | 100.00% | 0.39% | |
| WELLINGTON MANAGEMENT GROUP LLP | 02/12/2025 | 180,157 | $408,956 | 14.71% | 0.37% |
| PANAGORA ASSET MANAGEMENT INC | 02/13/2025 | 173,518 | $393,886 | -45.67% | 0.35% |
| MYDA ADVISORS LLC | 02/13/2025 | 171,200 | $388,624 | 100.00% | 0.35% |
| FEDERATED HERMES, INC. | 02/13/2025 | 147,347 | $334,478 | 37,876.03% | 0.30% |
| BANK OF NEW YORK MELLON CORP | 02/04/2025 | 141,148 | $320,406 | -10.72% | 0.29% |
| JANE STREET GROUP, LLC | 02/14/2025 | 118,636 | $269,304 | -24.77% | 0.24% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 117,500 | $266,725 | 34.90% | 0.24% |
| WALLEYE CAPITAL LLC | 02/13/2025 | 110,988 | $251,943 | -72.39% | 0.23% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 109,260 | $248,020 | -13.18% | 0.22% |
| CANTOR FITZGERALD, L. P. | 02/14/2025 | 100,000 | $224,000 | 100.00% | 0.20% |
| THRIVENT FINANCIAL FOR LUTHERANS | 02/10/2025 | 95,327 | $216,000 | 100.00% | 0.19% |
| TD ASSET MANAGEMENT INC | 02/11/2025 | 88,600 | $201,122 | 0.00% | 0.18% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 02/14/2025 | 87,675 | $199,022 | 100.00% | 0.18% |
| TCG CROSSOVER MANAGEMENT, LLC | 02/14/2025 | 86,795 | $197,025 | 0.00% | 0.18% |
| ARISTIDES CAPITAL LLC | 02/13/2025 | 75,400 | $171,158 | 100.00% | 0.15% |
| BARCLAYS PLC | 02/13/2025 | 71,617 | $163,000 | 17.16% | 0.15% |
| ENGINEERS GATE MANAGER LP | 02/14/2025 | 67,435 | $153,077 | 242.97% | 0.14% |
| ROYAL BANK OF CANADA | 02/14/2025 | 64,742 | $147,000 | -25.72% | 0.13% |
| ALLIANCEBERNSTEIN L.P. | 02/12/2025 | 64,630 | $146,710 | 0.00% | 0.13% |
| RHUMBLINE ADVISERS | 01/30/2025 | 63,421 | $143,955 | 4.71% | 0.13% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Cabaletta Bio, Inc. institutional Ownership - FAQ's
During the previous two years, 140 institutional investors and hedge funds held shares of Cabaletta Bio, Inc.. The most heavily invested institutionals were:
T. Rowe Price Investment Management, Inc.: 4.07 M
ADAGE CAPITAL PARTNERS GP, L.L.C.: 3.63 M
BlackRock Funding, Inc. /DE: 3.4 M
VANGUARD GROUP INC: 2.87 M
Bain Capital Life Sciences Investors, LLC: 2.76 M
JENNISON ASSOCIATES LLC: 2.51 M
78.60% of Cabaletta Bio, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 42.15 M shares in the last 24 months. This purchase volume represents approximately $112.11 M in transactions.